IRTC vs. BSX
IRTC (iRhythm Technologies, Inc.) and BSX (Boston Scientific Corporation) are both stocks. Both operate in the Medical Devices industry within the Healthcare sector. Over the past 5 years, IRTC returned 11.29%/yr vs 2.89%/yr for BSX. At a 0.30 correlation, their price movements are largely independent.
Performance
IRTC vs. BSX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IRTC achieves a -40.54% return, which is significantly higher than BSX's -49.99% return.
IRTC
- 1D
- -3.36%
- 1M
- -12.67%
- YTD
- -40.54%
- 6M
- -41.99%
- 1Y
- -24.99%
- 3Y*
- -0.05%
- 5Y*
- 11.29%
- 10Y*
- —
BSX
- 1D
- -0.63%
- 1M
- -15.61%
- YTD
- -49.99%
- 6M
- -51.85%
- 1Y
- -54.23%
- 3Y*
- -2.74%
- 5Y*
- 2.89%
- 10Y*
- 7.66%
IRTC vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IRTC iRhythm Technologies, Inc. | -40.54% | 96.78% | -15.76% | 14.27% | -20.41% | -50.39% | 248.38% | -2.00% | 23.96% | 86.83% |
BSX Boston Scientific Corporation | -49.99% | 6.75% | 54.51% | 24.94% | 8.92% | 18.16% | -20.50% | 27.96% | 42.56% | 14.61% |
Correlation
The correlation between IRTC and BSX is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.31 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.30 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since Oct 21, 2016 | 0.30 |
Fundamentals
IRTC:
$3.43B
BSX:
$71.28B
IRTC:
-$0.85
BSX:
$2.38
IRTC:
4.35
BSX:
3.46
IRTC:
21.27
BSX:
2.76
IRTC:
$787.85M
BSX:
$20.62B
IRTC:
$559.39M
BSX:
$14.52B
IRTC:
-$3.10M
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IRTC vs. BSX — Risk / Return Rank
IRTC
BSX
IRTC vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iRhythm Technologies, Inc. (IRTC) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IRTC | BSX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.59 | -1.57 | +0.98 |
Sortino ratioReturn per unit of downside risk | -0.69 | -2.40 | +1.71 |
Omega ratioGain probability vs. loss probability | 0.92 | 0.65 | +0.27 |
Calmar ratioReturn relative to maximum drawdown | -0.56 | -0.98 | +0.42 |
Martin ratioReturn relative to average drawdown | -1.20 | -2.25 | +1.05 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IRTC | BSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.59 | -1.57 | +0.98 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.18 | 0.11 | +0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.28 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.25 | 0.19 | +0.06 |
Drawdowns
IRTC vs. BSX - Drawdown Comparison
The maximum IRTC drawdown since its inception was -84.39%, smaller than the maximum BSX drawdown of -89.15%. Use the drawdown chart below to compare losses from any high point for IRTC and BSX.
Loading charts...
Drawdown Indicators
| IRTC | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.39% | -89.15% | +4.76% |
Max Drawdown (1Y)Largest decline over 1 year | -44.25% | -55.91% | +11.66% |
Max Drawdown (3Y)Largest decline over 3 years | -53.83% | -55.91% | +2.08% |
Max Drawdown (5Y)Largest decline over 5 years | -66.03% | -55.91% | -10.12% |
Max Drawdown (10Y)Largest decline over 10 years | — | -55.91% | — |
Current DrawdownCurrent decline from peak | -60.70% | -55.91% | -4.79% |
Average DrawdownAverage peak-to-trough decline | -37.04% | -38.75% | +1.71% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 20.80% | 24.31% | -3.51% |
Volatility
IRTC vs. BSX - Volatility Comparison
The current volatility for iRhythm Technologies, Inc. (IRTC) is 12.23%, while Boston Scientific Corporation (BSX) has a volatility of 16.24%. This indicates that IRTC experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IRTC | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.23% | 16.24% | -4.01% |
Volatility (6M)Calculated over the trailing 6-month period | 31.50% | 32.81% | -1.31% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.42% | 34.64% | +7.78% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 63.40% | 25.66% | +37.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 61.79% | 27.29% | +34.50% |
Dividends
IRTC vs. BSX - Dividend Comparison
Neither IRTC nor BSX has paid dividends to shareholders.
Financials
IRTC vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between iRhythm Technologies, Inc. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
IRTC vs. BSX - Profitability Comparison
IRTC - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, iRhythm Technologies, Inc. reported a gross profit of 141.35M and revenue of 199.39M. Therefore, the gross margin over that period was 70.9%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
IRTC - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, iRhythm Technologies, Inc. reported an operating income of -16.19M and revenue of 199.39M, resulting in an operating margin of -8.1%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
IRTC - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, iRhythm Technologies, Inc. reported a net income of -13.93M and revenue of 199.39M, resulting in a net margin of -7.0%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
IRTC and BSX have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BSX has higher volatility (16.24%) compared to IRTC (12.23%). In terms of maximum drawdown, IRTC dropped -84.39% vs BSX's -89.15%.
IRTC currently has the higher Sharpe Ratio (-0.59 vs -1.57), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IRTC and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer